REVCOVI FDA approval date

The FDA approved REVCOVI on 5 Oct 2018.

FDA approval date
5 Oct 2018

Drug identity has not yet been verified against registry records

Also recorded as ELAPEGADEMASE-LVLR

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-10-05DayREVCOVIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761092", "applicant_as_listed_by_fda": "CHIESI USA INC", "brand_names": ["REVCOVI"], "active_ingredients": ["ELAPEGADEMASE-LVLR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20181005", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026